Health Care/Hospital
Next Generation Refractive Surgery to LASIK and SMILE Now Available for Clinical Review
Pioneer surgeon Dr Natasha Lim is among the first in Singapore to offer Smooth Incision Lenticular Keratomileusis (SILK) procedure in their clinics. SINGAPORE, Aug. 18, 2025 /PRNewswire/ -- Dr. Natasha Lim, an internationally renowned surgeon in Ophthalmology, has introduced an alternative to est...
2025-08-18 11:00
2220
Herbalgy, Pain Management Expert, Harnesses the Wisdom of Traditional Chinese Medicine to Safeguard Hong Kong's Health, Proudly Appoints Moses Chan as Brand Ambassador
Download high-resolution images: https://cutt.ly/IrGBefFJ
2025-08-18 10:00
2349
New support group to provide social and community support for neurofibromatosis patients
Co-founded by individuals living with this rare genetic condition, the Neurofibromatosis Society Singapore seeks to close gaps in mental and emotional care SINGAPORE, Aug. 18, 2025 /PRNewswire/ -- A new patient-led support group, the Neurofibromatosis Society (NFS)Singapore, has been recently re...
2025-08-18 09:00
2047
Saigon Technology Drives Industry-Specific AI Transformation, Moving Businesses Beyond SaaS Limitations
Vietnamese software leader leverages AI and domain expertise to help industries modernize workflows and reduce long-term tech costs. HO CHI MINH CITY, Vietnam, Aug. 15, 2025 /PRNewswire/ -- As global businesses outgrow generic SaaS tools, Saigon Technology is delivering next-gen, AI-powered cust...
2025-08-15 10:00
2678
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Shanghai, Aug. 15, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that etrasimod (VELSIPITY®) has be...
2025-08-15 09:35
2566
TraceLink Accelerates Supply Chain Transformation with New OPUS Platform Capabilities for an AI-Powered Future
BOSTON, Aug. 14, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences and healthcare supply chain, today announced significant new platform enhancements to drive supply chain transformation with itsOrchestration Platfor...
2025-08-14 22:00
2253
Sisram Medical will Report H1 2025 Financial Results on August 20 and Hold a Conference Call on August 21
H1 2025 conference call to be held on August 21, at 8:30 a.m. Eastern Time HONG KONG, Aug. 14, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred to as the "Group"), a global consumer wellness group featuring a first-of...
2025-08-14 20:00
3077
Leads Biolabs Announces Completion of Patient Enrollment in Pivotal Trial of Opamtistomig Monotherapy for Extrapulmonary Neuroendocrine Carcinoma
NANJING, China, Aug. 14, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the successful completion of patient enrollment in the ongoing single-arm, pivotal registrational clinical trial (CTR20213023) for Opamtistomig (LB...
2025-08-14 17:38
3479
Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden
Integrated into Cortellis Regulatory Intelligence, new AI capability helps regulatory teams streamline access to critical intelligence and understand requirements with ease LONDON, Aug. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, ...
2025-08-14 15:00
1802
Medulla Expands Global Footprint with Strategic Launch in Singapore
SINGAPORE, Aug. 14, 2025 /PRNewswire/ -- Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare advertising agencies, has announced its expansion intoSingapore, establishing a strategic hub to serve the Asia-Pacific region. Known for its expertise in solving healthcare chall...
2025-08-14 13:30
2489
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis
SHANGHAI, Aug. 14, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the Taiwan Food and Drug Adminis...
2025-08-14 12:02
2746
Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide
* Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a billion people affected by Non-Alcoholic Fatty Liver Disease (NAFLD) * NAFLD affects 1 in 4 people globally (1.2 billion), with 188 million patients in India—most undiagnosed until irr...
2025-08-14 08:00
2522
The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association, and CurePSP Join Forces to Award $2.5 Million in Neurodegenerative Disease Research Grants from 2025 Tauopathy Challenge Workshop
Established in 2023, the Tauopathy Challenge Workshop aims to bridge the gap in funding of novel neurodegenerative research for primary tauopathies, including Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), and Frontotemporal Dementias (FTDs). FORT WORTH, Texas, Aug. 13, 2...
2025-08-13 20:00
2228
New Study Demonstrates Superiority of EggNest™ Complete Radiation Protection System in Comprehensive Protection for the Entire Interventional Team
MINNEAPOLIS, Aug. 13, 2025 /PRNewswire/ -- A recent study published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) highlights the effectiveness of the EggNest™ Complete radiation shielding system, demonstrating its superior ability to protect all personnel in...
2025-08-13 19:30
1850
Telitacicept Meets Primary Endpoint in Phase III Trial for Primary Sjögren's Syndrome in China
YANTAI, China, Aug. 13, 2025 /PRNewswire/ -- On August 13th, Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met the primary endpoint in its Phase III clinical trial for the treatment of primary Sjögren's syndr...
2025-08-13 17:57
2294
Pioneering Freeze-Dried Technology in Vietnam: Nature Foods Company Introduces Convenient and Healthy Eating Solutions
HO CHI MINH CITY, Vietnam, Aug. 13, 2025 /PRNewswire/ -- Amid rapid urbanization and an increasingly fast-paced lifestyle,Vietnam's ready-to-eat (RTE) food market is witnessing remarkable growth. In 2024, the market value reached approximatelyUSD 430 million and is projected to nearly triple to U...
2025-08-13 16:41
2778
Avive Health to host Queensland's first Empax clinic in landmark mental health partnership with Emyria
BRISBANE, Australia, Aug. 13, 2025 /PRNewswire/ -- Avive Health ("Avive"), an Australian-owned private mental health provider, has announced a major national partnership with Emyria Limited (ASX: EMD), marking a significant milestone in the evolution of evidence-based, reimbursable mental heal...
2025-08-13 15:40
2636
Hospital Management Asia 2025: Shaping the Future of Asian Healthcare
HO CHI MINH CITY, Vietnam, Aug. 13, 2025 /PRNewswire/ -- Hospital Management
Asia (HMA)
2025-08-13 15:19
2620
Prince Court Medical Centre Strengthens Malaysia's Position as a Global Healthcare Destination with First Kelly Procedure
KUALA LUMPUR, Malaysia, Aug. 13, 2025 /PRNewswire/ -- Prince Court Medical
Centre has placedMalaysia firmly on the global medical tourism map by
successfully performing the country's first Kelly procedure, an advanced
reconstructive surgery for rare congenital urological conditions.
2025-08-13 15:16
2359
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration
SINGAPORE, Aug. 13, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company ") today issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua ("Dr....
2025-08-13 09:44
5239
Week's Top Stories
Most Reposted
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 298 media titles]
2026-06-04 23:55
DayOne Appoints Nicolas Aguzin to Board of Directors, Strengthening Global Governance and Capital Markets Expertise
[Picked up by 281 media titles]
2026-05-29 15:50Pudu Robotics and Shenzhen CTID Co. Ltd Launch the World's First Full-Scenario Robot-Serviced Hotel Project
[Picked up by 275 media titles]
2026-06-01 18:00Creality 3D Successfully Listed in Hong Kong
[Picked up by 271 media titles]
2026-05-29 11:21
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
[Picked up by 269 media titles]
2026-05-30 11:58
Most Read
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
2026-05-30 11:58
8232
AMTD's Successful Completion of Acquisition of The Ritz-Carlton, Perth, Valued at A$280 Million
2026-05-29 21:50
7623
Creality 3D Successfully Listed in Hong Kong
2026-05-29 11:21
7180
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
2026-05-29 22:00
6740